BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25155966)

  • 1. Enteral granulocyte-colony stimulating factor and erythropoietin early in life improves feeding tolerance in preterm infants: a randomized controlled trial.
    El-Ganzoury MM; Awad HA; El-Farrash RA; El-Gammasy TM; Ismail EA; Mohamed HE; Suliman SM
    J Pediatr; 2014 Dec; 165(6):1140-1145.e1. PubMed ID: 25155966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enteral erythropoietin on feeding-related complications in preterm newborns: A pilot randomized controlled study.
    Omar OM; Massoud MN; Ghazal H; Hassouna H; Somaa MF
    Arab J Gastroenterol; 2020 Mar; 21(1):37-42. PubMed ID: 32241699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated amniotic fluid-like solution given enterally to neonates after obstructive bowel surgeries: A randomized controlled trial.
    El-Farrash RA; Gad GI; Abdelkader HM; Salem DAD; Fahmy SA
    Nutrition; 2019 Oct; 66():187-191. PubMed ID: 31310960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g.
    Karagol BS; Zenciroglu A; Okumus N; Polin RA
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):223-8. PubMed ID: 22664861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G; Walia M; Bala H; Singh S
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral granulocyte colony-stimulating factor for the treatment of mild (stage I) necrotizing enterocolitis: a placebo-controlled pilot study.
    Canpolat FE; Yurdakök M; Korkmaz A; Yiğit S; Tekinalp G
    J Pediatr Surg; 2006 Jun; 41(6):1134-8. PubMed ID: 16769348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells.
    Pierelli L; Menichella G; Scambia G; Teofili L; Iovino S; Serafini R; Benedetti Panici P; Salerno G; Rumi C; Zini G
    Bone Marrow Transplant; 1994 Jul; 14(1):23-30. PubMed ID: 7524905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral administration of a simulated amniotic fluid in preventing feeding intolerance in very low birthweight neonates: A randomized controlled trial.
    El-Farrash RA; Ismail RIH; El-Sheimy MS; Saleh AM; Saleh GA
    Nutrition; 2023 Mar; 107():111932. PubMed ID: 36580871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow versus rapid enteral feeding advancement in preterm newborn infants 1000-1499 g: a randomized controlled trial.
    Krishnamurthy S; Gupta P; Debnath S; Gomber S
    Acta Paediatr; 2010 Jan; 99(1):42-6. PubMed ID: 20002013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P; Messer J; Paupe A; Espagne S; Kacet N; Mouchnino G; Klosowski S; Krim G; Lescure S; Le Bouedec S; Meyer P; Astruc D
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy analysis of recombinant human erythropoietin in the treatment of lower-risk myelodysplastic syndromes].
    Zhang H; Qin T; Xu Z; Fang L; Pan L; Hu N; Qu S; Zhang Y; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):18-23. PubMed ID: 24602726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial.
    Pasha YZ; Ahmadpour-Kacho M; Hajiahmadi M; Hosseini MB
    Indian Pediatr; 2008 Jan; 45(1):25-8. PubMed ID: 18250501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteral L-arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a double-blind randomized pilot study of efficacy and safety.
    Polycarpou E; Zachaki S; Tsolia M; Papaevangelou V; Polycarpou N; Briana DD; Gavrili S; Kostalos C; Kafetzis D
    JPEN J Parenter Enteral Nutr; 2013 Sep; 37(5):617-22. PubMed ID: 23329787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.